Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease

In Vivo

Volumn 23, Issue 6, 2009, Pages 949-954

  Kucukhuseyin, Ozlem ^a   Aydogan, Hulya Yilmaz ^a   Isbir, C Selim ^b   Isbir, Turgay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Coronary artery disease; Diabetes mellitus; Genetics; Polymorphism; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RAGE GENE; RESTRICTION FRAGMENT; SMOKING; TURKEY (REPUBLIC);

EID: 75149186055     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gerszten RE and Rosenzweig A: Coronary Atherosclerosis. In: Principles of Molecular Medicine. Chicago; Humana Press and Jameson JL (ed.). 1998.
2. Novelli G, Borgiani P, Giardina E, Mango R, Contino G, Romeo F and Mehta JL: Role of genetics in prevention of coronary atherosclerosis. Curr Opin Cardiol 18: 368-371, 2003.
3. Ross R: The pathogenesis of atherosclerosis. In: Braunwald Heart Disease A Textbook of Cardiovascular Medicine, 4th edition, An HBJ International Edition. Philadelpia: Saunders 1(36): 1106-1124, 1992.
4. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
5. Ramasamy R, Vannucci SJ, Yan DSS, Herold K, Yan SF and Schmidt AM: Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration and inflammation. Glycobiol 15(7): 16R-28R, 2005.
6. Baldwin JS, Lee L, Leung TK, Muruganandam A and Mutus B: Identification of the site of non-enzymatic glycation of glutathione peroxidase: rationalization of the glycation-related catalytic alterations on the basis of three-dimensional protein structure. Biochim Biophys Acta 1247: 60-64, 2005.
7. Simm A, Casselmann C, Schubert A, Hofmann S, Reimann A and Silber RE: Age-associated changes of AGE-receptor expression: RAGE up-regulation is associated with human heart dysfunction. Experimental Gerontology 39: 407-413, 2004.
8. Wautier JL and Schmidt AM: Protein glycation: A firm link to endothelial cell dysfunction. Circ Res 95: 233-238, 2004.
9. Forbes JM, Soldatos G and Thomas MC: Below the radar: Advanced glycation end products that detour around the side. Clin Biochem Rev 26: 123-134, 2005.
10. Baynes JW and Thorpe SR: Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med 28(12): 1708-1716, 2000.
11. Bierhaus A, Hoffman MA, Ziegler R and Mawroth PP: AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus-The AGE concept. Cardiovasc Res 37: 586-600, 1998.
12. Singh R, Barden A, Mori T and Beilin L: Advanced glycation end products: A review. Diabetologia 44: 129-146, 2001.
13. Yan SF, Ramasamy R, Naka Y and Schmidth AM: Glycation, inflammation, and RAGE. A scaffold for the macrovascular complications of diabetes and beyond. Circ Res 93: 1159-1169, 2003.
14. Hudson BI, Stickland MH, Futers TS and Grant PJ: Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50: 1505-1511, 2001.
15. Hudson B, Hofmann M, Bucciarelli L, Wendt T, Moser B, Lu Y, Qu W, Stern D, D'Agati V, Yan S, Grant and Schmidt A: Glycation and diabetes: The RAGE connection. Curr Sci 83(12): 1515-1521, 2002.
16. Li J and Schmidt AM: Characterization and functional analysis of the promote of RAGE, the receptor for advanced glycation end products. Biol Chem 273(26): 16498-16506, 1997.
17. Hudson B, Wendt T, Bucciareli L, Rong L, Naka Y, Yan S and Schmidt A: Diabetic vascular disease: It's all RAGE: Forum review. Antiox Red Signal 7(11-12): 1588-1600, 2005.
18. Szweda PA, Friguet B and Szweda LI: Proteolysis, free radicals and aging. Free Radic Biol Med 33: 29-36, 2002.
19. Adachi T, Ohta H, Hirano K, Hayashi K and Marklund SL: Non-enzyme glycation of human extracellular superoxide dismutase. Biochem J 279: 263-267, 1991.
20. Falcone C, Campo I, Emanuele E, Buzzi MP, Geroldi D, Belvito C, Zorzetto M, Sbarsi I and Cuccia M: -374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Clinica Chimica Acta 354: 111-116, 2005.
21. Miller SA, Dykes DD and Polesky HF: A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215, 1998.
22. Falcone C, Campo I, Emanuele E, Buzzi MP, Zorzetto M, Sbarsi I and Cuccia M: Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int J Mol Med 14: 1061-1064, 2004.
23. Kankova K, Zahejsky J, Marova I, Muzik J, Kuhrova V, Blazkova M, Znojil V, Beranek M and Vacha J: Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J Diabetes Compl 15: 185-192, 2001.
24. Falcone C, Geroldi D, Buzzi MP, Emanuele E, Yilmaz C, Fontana JM, Vignali L, Boiocchi C, Sbarsi I and Cuccia M: The -374 T/A RAGE gene polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. Arch Med Res 39: 320-325, 2008.
25. Bolli G, DeFeo P, Compagnucci P, Angeletti G, Sansteusanio F, Brunetti P and Gerich J: Abnormal glucose counter regulation in insulin dependent diabetes mellitus: Interaction of anti-insulin antibodies and impaired glucagon and norepinephrine secretion. Diabetes 32: 134, 1983.
26. Foster DW. Fauci AS, Braunwald E, Iselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL and Longo DL: Diabetes mellitus. In: Harrison's Principles of Internal Medicine, 14th ed. New York: The McGraw-Hill Companies Inc. pp: 2060-2080, 1998.
27. Kobata A: Structures and functions of the sugar chains of glycoproteins. Eur J Biochem 209: 483-501, 1992.
28. Allen HJ and Kisailus EC: Glycoconjugates: Composition, Structure and Function. New York: Marcel Dekker Inc. pp. 685, 1992.
29. Feizi T: Cell-cell adhesion and membrane glycosylation. Curr Opin Struc Biol 1: 766-770, 1991.
30. Varki A: Biological roles of oligosaccharides. In: Tools for Glycobiology. Novato: Glyco Inc. 7.18-7.32, 2001.
31. Pollard TD and Earnshaw WC: Cell Biology. Philadelphia: Saunders, pp. 316, 2004.
32. Nelson DL and Cox MM: Principles of Biochemistry. New York: Lehninger. pp. 261-268, 2005.
33. Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M and Grant PJ: The functional -374T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes 52(3): 891-894, 2003.
34. Hudson BI, Sticland MH, Futers TS and Grant PJ: Study of the -429 T/C and -374 T/A receptor for advanced glycation end products promoter polymorphisms in diabetic or nondiabetic subjects with macrovascular disease. Diabetes Care 24(11): 2004,2001.
35. Kirbis J, Milutinović A, Steblovnik K, Teran N, Terzić R and Zorc M: The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Coll Antropol 28(2): 611-616, 2004.
36. Jixiong X, Bilin X, Minggong Y and Shuqin L: -429 T/C and -374 T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 26(9): 2696-2697, 2003.
37. Bohlender JM, Franke S, Stein G and Wolf G: Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 289: 645-659, 2005.
38. Santos KG, Canani LH, Gross JL, Tschiedel B, Souto KEP and Roisenberg I: The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol Gen Metab 85: 149-156, 2005.
39. Zee RYL, Romero JR, Gould JL, Ricupero DA and Ridker PM: Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke. Stroke 37: 1686-1690, 2006.